PF-Atlas › Clinical Trials › NCT00449878
Liprotamase Efficacy Trial in Patients With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Liprotamase · Phase 3
Registry ID
NCT00449878
Phase
Phase 3
Status
Completed
Drug / intervention
Liprotamase
Sponsor
Anthera Pharmaceuticals
Start
2007-05
About this trial
Liprotamase is evaluated in NCT00449878, a Phase 3 idiopathic pulmonary fibrosis study sponsored by Anthera Pharmaceuticals. Current status: Completed.
Explore related
Related trials
Medical disclaimer. This page summarizes public trial data for NCT00449878 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.